Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

2015 ACR/ARHP Annual Meeting: T Follicular Helper Cells Emerge as Potential Treatment Target for Autoimmune Diseases

Mary Beth Nierengarten  |  Issue: February 2016  |  February 17, 2016

The study found that the circulating Tfh-like cells were expanded in the blood of SLE patients compared with controls, as noted by the high levels of CXCR5, inducible T cell costimulator (ICOS) and programmed death 1 (PD-1) protein found in the SLE patients. Research has shown that expression of CXCR5, ICOS and PD-1 are markers of circulating Tfh-like cells. Compared with controls, expression of PD-1 was significantly elevated in circulating Tfh-like cells in the patients with SLE and PD-1 expression among patients with high CXCR5 circulating Tfh-like cells correlated with SLEDAI, frequency of circulating plasmablasts and anti-double-stranded-DNA antibody positivity. No relationship was found with duration of disease or past organ injury.

This study, said Dr. Craft, showed that Tfh-like cells are correlated with disease activity and aberrant B cell function in patients with SLE.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

New Therapies?

According to Dr. Craft, this type of research will help us better understand the function and role of Tfh cells in autoimmune diseases and help identify what, ultimately, is the goal of this research—better treatment.

“By understanding these events, we better utilize current, or develop new, therapies that block their provision of pathogenic B cell help in the rheumatic disease,” he said, ending with a final question left for ongoing and future research to answer.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Are therapies that block Tfh–B cell interactions in SLE, and other rheumatic disease, clinically effective, and if so, does therapeutic efficacy correlate with Tfh-cell or circulating B cell numbers and function?” he asked.


Mary Beth Nierengarten is a freelance medical journalist based in St. Paul, Minn.

Second Chance

If you missed this session, it’s not too late. Catch it on SessionSelect

http://acrannualmeeting.org/resources/sessionselect

References

  1. Craft JE. Follicular helper T cells in immunity and systemic autoimmunity. Nat Rev Rheumatol. 2012 May 1;8(6):337–347.
  2. Choi JY, Ho JH, Pasoto SG, et al. Circulating follicular helper-like T cells in systemic lupus erthematosus: Association with disease activity. Arthritis Rheumatol. 2015 Apr;67(4):988–999.

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsMeeting ReportsResearch Rheum Tagged with:2015 ACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)Autoimmune diseaseResearchtherapyTreatment

Related Articles

    High-Salt Diet May Trigger Gene Silencing & a Lupus Phenotype

    August 15, 2016

    New research has demonstrated that a high-salt diet may increase the differentiation of follicular helper T cells (Tfh). A high-salt diet also increased lupus features in MRL/lpr mice, suggesting that the genes that increased expression in response to salt intake were similar to the genes that had increased expression in lupus CD4+ T cells…

    T Cells in Systemic Lupus Erythematosus

    August 1, 2011

    Progress toward targeted therapy

    Is B a Key to Autoimmune Therapy?: B Cell–targeted Therapies in Autoimmune Disease

    January 1, 2010

    A perspective on B cell–targeted therapies in autoimmune disease

    Peripheral Helper Cells May Provide Clue to RA Pathology

    February 27, 2017

    Research has identified a subset of T cells, peripheral helper (TPH) cells, which may promote pathological B cell responses and antibody production in patients with seropositive RA. TPH cells also express chemokine receptors, enabling them to infiltrate inflamed parts of the body and stimulate B cells to produce antibodies…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences